News & Articles

New testing capacity complements EKF’s test kit manufacturing and point-of-care diagnostic instrument business

Stratix Labs launches a new product designed to simplify the delivery of reference microorganisms to solid media

The first contract research organization to offer the GA-map microbiome test

Scientists identify a new link between certain molecules produced by the microbiome and the function of a protein that impacts gut inflammation

Which new products helped to accelerate your lab work this year?

We’ve rounded up the latest clinical news and technological advancements which made waves at this year’s conference

Teams uses mathematical modelling study to guide preparations for future health strategies

Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease.

The shared CLIA lab aims to help diagnostics start-ups, including Australian-based Minomic, more rapidly enter the U.S. market

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance

DNA/RNA Shield – DirectDetect reagent eliminates RNA extraction for rapid deployment of COVID-19 tests

A study by researchers at Oxford University found that we are amidst the biggest decrease in life expectancy since WWII

Discover innovative POC technology designed to meet today’s emergency care needs and inform effective management of cardiac patients

Offering user-friendly, efficient specimen collection, the Combo Swab is expected to dramatically improve COVID-19 testing efficiency

Keep up to date with the latest technologies and techniques advancing clinical diagnostics

Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond

QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant

Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks

Patients with underlying heart problems are more than four times as likely to die from COVID-19

Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home

Watch this on-demand webinar to gain insights into the design and development pipeline for rapid response solutions